MovDisordV3, Ncbi, Merge, bibRecord, 003A96

Encephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome.

Identifieur interne : 003A96 ( Ncbi/Merge ); précédent : 003A95; suivant : 003A97

Encephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome.

Auteurs : Fanny Duval [France] ; Olivier Flabeau ; Julien Razafimahefa ; Umberto Spampinato ; François Tison

Source :

Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2013.

RBID : pubmed:23495033

English descriptors

KwdEn :
- Aged, Akathisia, Drug-Induced (physiopathology), Antiparkinson Agents (therapeutic use), Brain Diseases (etiology), Delusions (chemically induced), Depressive Disorder, Major (complications), Depressive Disorder, Major (drug therapy), Drug Interactions, Drug Therapy, Combination, Female, Humans, Indans (adverse effects), Indans (therapeutic use), Myoclonus (chemically induced), Myoclonus (physiopathology), Neuroprotective Agents (adverse effects), Neuroprotective Agents (therapeutic use), Parkinson Disease (complications), Parkinson Disease (drug therapy), Serotonin Syndrome (etiology), Serotonin Syndrome (physiopathology), Serotonin Uptake Inhibitors (adverse effects), Serotonin Uptake Inhibitors (therapeutic use), Sertraline (adverse effects), Sertraline (therapeutic use).
MESH :
- chemical , adverse effects : Indans, Neuroprotective Agents, Serotonin Uptake Inhibitors, Sertraline.
- chemical , therapeutic use : Antiparkinson Agents, Indans, Neuroprotective Agents, Serotonin Uptake Inhibitors, Sertraline.
- chemically induced : Delusions, Myoclonus.
- complications : Depressive Disorder, Major, Parkinson Disease.
- drug therapy : Depressive Disorder, Major, Parkinson Disease.
- etiology : Brain Diseases, Serotonin Syndrome.
- physiopathology : Akathisia, Drug-Induced, Myoclonus, Serotonin Syndrome.
- Aged, Drug Interactions, Drug Therapy, Combination, Female, Humans.

DOI: 10.1002/mds.25416
PubMed: 23495033

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 000985
to stream PubMed, to step Curation: 000985
to stream PubMed, to step Checkpoint: 000A10

Links to Exploration step

pubmed:23495033

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Encephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome.</title>
<author><name sortKey="Duval, Fanny" sort="Duval, Fanny" uniqKey="Duval F" first="Fanny" last="Duval">Fanny Duval</name>
<affiliation wicri:level="1"><nlm:affiliation>Service de Neurologie, CHU Bordeaux, Pessac, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de Neurologie, CHU Bordeaux, Pessac</wicri:regionArea>
<wicri:noRegion>Pessac</wicri:noRegion>
<wicri:noRegion>Pessac</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Flabeau, Olivier" sort="Flabeau, Olivier" uniqKey="Flabeau O" first="Olivier" last="Flabeau">Olivier Flabeau</name>
</author>
<author><name sortKey="Razafimahefa, Julien" sort="Razafimahefa, Julien" uniqKey="Razafimahefa J" first="Julien" last="Razafimahefa">Julien Razafimahefa</name>
</author>
<author><name sortKey="Spampinato, Umberto" sort="Spampinato, Umberto" uniqKey="Spampinato U" first="Umberto" last="Spampinato">Umberto Spampinato</name>
</author>
<author><name sortKey="Tison, Francois" sort="Tison, Francois" uniqKey="Tison F" first="François" last="Tison">François Tison</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="doi">10.1002/mds.25416</idno>
<idno type="RBID">pubmed:23495033</idno>
<idno type="pmid">23495033</idno>
<idno type="wicri:Area/PubMed/Corpus">000985</idno>
<idno type="wicri:Area/PubMed/Curation">000985</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000A10</idno>
<idno type="wicri:Area/Ncbi/Merge">003A96</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Encephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome.</title>
<author><name sortKey="Duval, Fanny" sort="Duval, Fanny" uniqKey="Duval F" first="Fanny" last="Duval">Fanny Duval</name>
<affiliation wicri:level="1"><nlm:affiliation>Service de Neurologie, CHU Bordeaux, Pessac, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de Neurologie, CHU Bordeaux, Pessac</wicri:regionArea>
<wicri:noRegion>Pessac</wicri:noRegion>
<wicri:noRegion>Pessac</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Flabeau, Olivier" sort="Flabeau, Olivier" uniqKey="Flabeau O" first="Olivier" last="Flabeau">Olivier Flabeau</name>
</author>
<author><name sortKey="Razafimahefa, Julien" sort="Razafimahefa, Julien" uniqKey="Razafimahefa J" first="Julien" last="Razafimahefa">Julien Razafimahefa</name>
</author>
<author><name sortKey="Spampinato, Umberto" sort="Spampinato, Umberto" uniqKey="Spampinato U" first="Umberto" last="Spampinato">Umberto Spampinato</name>
</author>
<author><name sortKey="Tison, Francois" sort="Tison, Francois" uniqKey="Tison F" first="François" last="Tison">François Tison</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Akathisia, Drug-Induced (physiopathology)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Brain Diseases (etiology)</term>
<term>Delusions (chemically induced)</term>
<term>Depressive Disorder, Major (complications)</term>
<term>Depressive Disorder, Major (drug therapy)</term>
<term>Drug Interactions</term>
<term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Humans</term>
<term>Indans (adverse effects)</term>
<term>Indans (therapeutic use)</term>
<term>Myoclonus (chemically induced)</term>
<term>Myoclonus (physiopathology)</term>
<term>Neuroprotective Agents (adverse effects)</term>
<term>Neuroprotective Agents (therapeutic use)</term>
<term>Parkinson Disease (complications)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Serotonin Syndrome (etiology)</term>
<term>Serotonin Syndrome (physiopathology)</term>
<term>Serotonin Uptake Inhibitors (adverse effects)</term>
<term>Serotonin Uptake Inhibitors (therapeutic use)</term>
<term>Sertraline (adverse effects)</term>
<term>Sertraline (therapeutic use)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Indans</term>
<term>Neuroprotective Agents</term>
<term>Serotonin Uptake Inhibitors</term>
<term>Sertraline</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Indans</term>
<term>Neuroprotective Agents</term>
<term>Serotonin Uptake Inhibitors</term>
<term>Sertraline</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Delusions</term>
<term>Myoclonus</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Depressive Disorder, Major</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Depressive Disorder, Major</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Brain Diseases</term>
<term>Serotonin Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Akathisia, Drug-Induced</term>
<term>Myoclonus</term>
<term>Serotonin Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Drug Interactions</term>
<term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">23495033</PMID>
<DateCreated><Year>2013</Year>
<Month>09</Month>
<Day>30</Day>
</DateCreated>
<DateCompleted><Year>2014</Year>
<Month>05</Month>
<Day>09</Day>
</DateCompleted>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>28</Volume>
<Issue>10</Issue>
<PubDate><Year>2013</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Encephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome.</ArticleTitle>
<Pagination><MedlinePgn>1464</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.25416</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duval</LastName>
<ForeName>Fanny</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Service de Neurologie, CHU Bordeaux, Pessac, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Flabeau</LastName>
<ForeName>Olivier</ForeName>
<Initials>O</Initials>
</Author>
<Author ValidYN="Y"><LastName>Razafimahefa</LastName>
<ForeName>Julien</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Spampinato</LastName>
<ForeName>Umberto</ForeName>
<Initials>U</Initials>
</Author>
<Author ValidYN="Y"><LastName>Tison</LastName>
<ForeName>François</ForeName>
<Initials>F</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2013</Year>
<Month>03</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000978">Antiparkinson Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007189">Indans</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018696">Neuroprotective Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017367">Serotonin Uptake Inhibitors</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>003N66TS6T</RegistryNumber>
<NameOfSubstance UI="C031967">rasagiline</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>QUC7NX6WMB</RegistryNumber>
<NameOfSubstance UI="D020280">Sertraline</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D017109">Akathisia, Drug-Induced</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D000978">Antiparkinson Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D001927">Brain Diseases</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D003702">Delusions</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000139">chemically induced</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D003865">Depressive Disorder, Major</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004347">Drug Interactions</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004359">Drug Therapy, Combination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D007189">Indans</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009207">Myoclonus</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000139">chemically induced</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D018696">Neuroprotective Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D020230">Serotonin Syndrome</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D017367">Serotonin Uptake Inhibitors</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D020280">Sertraline</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year>
<Month>11</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2013</Year>
<Month>1</Month>
<Day>22</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2013</Year>
<Month>2</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="aheadofprint"><Year>2013</Year>
<Month>3</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2013</Year>
<Month>3</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2013</Year>
<Month>3</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2014</Year>
<Month>5</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="doi">10.1002/mds.25416</ArticleId>
<ArticleId IdType="pubmed">23495033</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>France</li>
</country>
</list>
<tree><noCountry><name sortKey="Flabeau, Olivier" sort="Flabeau, Olivier" uniqKey="Flabeau O" first="Olivier" last="Flabeau">Olivier Flabeau</name>
<name sortKey="Razafimahefa, Julien" sort="Razafimahefa, Julien" uniqKey="Razafimahefa J" first="Julien" last="Razafimahefa">Julien Razafimahefa</name>
<name sortKey="Spampinato, Umberto" sort="Spampinato, Umberto" uniqKey="Spampinato U" first="Umberto" last="Spampinato">Umberto Spampinato</name>
<name sortKey="Tison, Francois" sort="Tison, Francois" uniqKey="Tison F" first="François" last="Tison">François Tison</name>
</noCountry>
<country name="France"><noRegion><name sortKey="Duval, Fanny" sort="Duval, Fanny" uniqKey="Duval F" first="Fanny" last="Duval">Fanny Duval</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003A96 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 003A96 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:23495033
   |texte=   Encephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:23495033" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Encephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome.

Encephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome.

Source :

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki